Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon β.
Secukinumab: first global approval.
Substance Name: MEDI 551
Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study.
In vitro assessment of the direct effect of laquinimod on basic functions of human neural stem cells and oligodendrocyte progenitor cells.
Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis.
MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions.
Genetic characterization of gliomas arising in patients with multiple sclerosis.
Impact of Repeated Topical-Loaded Manganese-Enhanced MRI on the Mouse Visual System.
Genotype-phenotype correlation for non-HLA disease associated risk alleles in multiple sclerosis.
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis.
Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
The Impact of Social Media on Dissemination and Implementation of Clinical Practice Guidelines: A Longitudinal Observational Study.
Biogen Idec to acquire full rights and control of Tysabri from Elan for upfront cash and contingent payments
Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer¿s disease and multiple sclerosis.
A biopsychosocial model of resilience for multiple sclerosis.
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim.
The role of endogenous antiradical protective system in multiple sclerosis.
1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells.
Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.
Pages
« first
‹ previous
…
211
212
213
214
215
216
217
218
219
…
next ›
last »